Financing channel feed – Endpoints News

Financing channel feed

Legend raises $200M from private investor after conference leaks PhIII Carvykti data

3 years ago

Vaxcyte to raise $500M from stock offering for PhIII study of pneumococcal vaccine

3 years ago

Gilde Healthcare bags $657M to fuel 'holistic' search for affordable drugs, technologies

3 years ago

European biotech VC Forbion closes two funds at $1.5B total in its biggest raises to date

3 years ago

VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year

3 years ago

Herceptin founder snags $158M for his UCLA-biotech partnership TORL BioTherapeutics

3 years ago

After raising $1.15B in just 10 weeks, Lux's Josh Wolfe shares his spending plans for his new VC fund

3 years ago

Briggs Morrison helms new MPM oncology startup with Pfizer Ventures, Polaris partners on board

3 years ago

Singaporean cell therapy biotech with off-the-shelf ambitions wraps modest IPO

3 years ago

Acelyrin files to go public in rare sign of biotech IPO

3 years ago

Keep ‘em coming: Lux Capital bags $1.15B as life sciences funds reel in one round after another in 2023

3 years ago

HSBC is moving to fill a big gap left by SVB's collapse. And they've recruited some familiar faces for the leap

3 years ago

Updated: Wellington puts a bow on new $476M private biotech fund

3 years ago

CDMO secures $31M Series A to build out Oklahoma manufacturing facility

3 years ago

Trio of VCs launches Gaelic-inspired Aer Therapeutics with $36M to prove itself in COPD around 2025

3 years ago

Biotech laser-focused on a single target nabs $105M for fibrosis, cancer trials

3 years ago

Biopharma venture funding falls to the lowest total since 2019 as startups ponder alternative paths

3 years ago

Science-whiz twins backed by a16z bring Function Oncology out of stealth

3 years ago

SPAC led by Biogen chairman Papadopoulos can't find a deal and will liquidate

3 years ago

Exclusive: Cell and gene therapy CDMO VintaBio emerges onto the scene with $64M and a new CEO

3 years ago

A new cell therapy biotech emerges to find solid tumor-killing immune cells in patients' blood

3 years ago

Contract manufacturer Phlow raises $36M to build out services

3 years ago

Canaan lands $650M for latest VC fund aimed at tech and drug development

3 years ago

OnKure Therapeutics nabs $60M as HDAC inhibitor awaits solid-tumor readouts

3 years ago

First page Previous page 36 37 383940 41 42 Next page Last page